A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanomaJoanna Poźniak, Jean‐Christophe Marine, Ada Nowosad et al.|Cell|2024Cited by 175
A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanomaJoanna Poźniak, Jean‐Christophe Marine, Dennis Pedri et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 20
The assembly of cancer-specific ribosomes by the lncRNA <i>LISRR</i> suppresses melanoma anti-tumour immunitySonia Cinque, Eleonora Leucci|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5